EXTRAMEDULLARY LEUKEMIA (EML) IN MYELODYSPLASTIC SYNDROMES (MDS) - NOT A TRUE INDICATION OF IMPENDING ACUTE MYELOID-LEUKEMIA (AML)

被引：0
|
作者：
EDENFIELD, WJ [1 ]
BYRD, JC [1 ]
AYLESWORTH, C [1 ]
DOW, NS [1 ]
DAWSON, N [1 ]
机构：
[1] WALTER REED ARMY MED CTR,WASHINGTON,DC 20307
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A631 / A631
页数：1
相关论文
共 50 条
  • [1] Extramedullary myeloid cell tumors in myelodysplastic-syndromes: Not a true indication of impending acute myeloid leukemia
    Byrd, JC
    Edenfield, WJ
    Dow, NS
    Aylesworth, C
    Dawson, N
    [J]. LEUKEMIA & LYMPHOMA, 1996, 21 (1-2) : 153 - 159
  • [2] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    ANDREEFF, M
    STONE, R
    YOUNG, C
    TONG, W
    ERVIN, T
    TAFURI, A
    KOLITZ, J
    RIFKIND, R
    KUFE, D
    MARKS, P
    [J]. LEUKEMIA, 1991, 5 (02) : 174 - 174
  • [3] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    [J]. LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [4] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
  • [5] ABSENCE OF REARRANGEMENTS OF THE NF1 GENE IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    PREUDHOMME, C
    QUESNEL, B
    VANRUMBEKE, M
    VACHEE, A
    LAI, JL
    FENAUX, P
    [J]. BLOOD, 1993, 82 (10) : A531 - A531
  • [6] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
    Padmanabhan, A.
    Block, A.
    Sait, S.
    Ford, L. A.
    O'Connor, T. L.
    Moysich, K. B.
    Baer, M. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] LOW-DOSE CYTARABINE (ARA-C) IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    MUFTI, GJ
    OSCIER, DG
    HAMBLIN, TJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 571 - 571
  • [8] MORPHOLOGY OF T(8-21) ACUTE MYELOID-LEUKEMIA MYELODYSPLASTIC SYNDROME (AML/MDS)
    HUTCHISON, R
    LAWRENCE, D
    MACCALLUM, J
    VARNEY, J
    DEHORITY, D
    WURSTERHILL, D
    BLOOMFIELD, C
    DAVEY, F
    [J]. LABORATORY INVESTIGATION, 1991, 64 (01) : A74 - A74
  • [9] Population pharmacokinetic modelling of decitabine in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Mistry, B.
    Gibiansky, L.
    Hussein, Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] MYELODYSPLASTIC SYNDROMES - THEIR HISTORY, EVOLUTION AND RELATION TO ACUTE MYELOID-LEUKEMIA
    LAYTON, DM
    MUFTI, GJ
    [J]. BLUT, 1986, 53 (06): : 423 - 436
12345